Tag search results
Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.
A city contractor must pay the family of a man killed in a 2004 sewage tank accident more than $5 million, a judge ruled Friday. Mike Cmos Jr. died in May 2004 when the roof of one of three large sewage digesters at Spokane’s wastewater treatment plant collapsed into the tank.
The Environmental Protection Agency is sorry. Sorry it didn’t approach the cleanup of the Spokane River in a regional way from the very start of the TMDL process. TMDL (for total maximum daily load) is jargon that translates, loosely, to “river cleanup plan.” In this case, it means the cleanup of phosphorus that feeds algae that sucks the river dry of dissolved oxygen when it dies.
Crafting a new plan to limit phosphorus discharges into the Spokane River will take at least another year, state and federal officials announced Friday. Phosphorus is harmful to the river’s aquatic health. Found in fertilizers and treated sewage, phosphorus contributes to algae blooms and water quality problems in the reservoir behind Long Lake Dam, including low levels of dissolved oxygen crucial for rainbow trout.
A multiyear effort to lower phosphorus levels in the Spokane River – and reduce algae blooms and improve water quality in the reservoir behind Long Lake Dam – has hit a major snag. The Environmental Protection Agency announced Thursday it erred when calculating phosphorus limits in permits for Idaho cities that discharge treated sewage into the river.
Don't worry, the soap police will not appear at your door July 1. That's the date Spokane County will become the first and only Washington county to require ultra-low phosphate dishwasher detergent. By 2010, every Washington county will follow Spokane County's lead under a new state law prohibiting the sale of dishwasher detergents with phosphorus contents higher than one-half of 1 percent.
State legislators want Spokane to go it alone this year in enforcing groundbreaking limits on phosphates in dish detergent. The state Senate this week approved a House bill that eliminates or weakens the strict phosphate restrictions that were supposed to become effective in two other counties July 1.
The death of a sewage plant maintenance worker in 2004 set the stage for a multimillion dollar project to build two egg-shaped sewage "digesters" at Spokane's wastewater treatment plant on Aubrey L. White Parkway. Crews are midway into the $45 million project to erect twin steel tanks, each capable of holding 2.85 million gallons of sewage sludge.
(From For the Record, March 23, 1998): Story incorrect: Terry Lawhead is operations director for the Downtown Spokane Partnership. Lawhead's title was unclear and the group's name was incorrect in a Sunday story. 1. Shortly after leaving detox, friends share a beer downtown. Photo by Shawn Jacobson/The Spokesman-Review 2. Van driver Glen Dowd shakes hands with a man in the "sobering unit" at the detox center. Dowd had just transported another man from the Deaconess Medical Center emergency room to detox. Photo by Shawn Jacobson/The Spokesman-Review
Burning a tiny hole deep within the brain can relieve some symptoms of Parkinson's disease for at least two years, a study found. The approach, called pallidotomy, has received considerable attention in recent years, and the latest study is among the largest to assess the operation.
Ribi ImmunoChem could have its new melanoma vaccine on Canadian markets by March, an official for the Hamilton pharmaceutical company said. Melacine, the company's submission for a melanoma vaccine, has cleared a 45-day preliminary review by the Canadian Health Protection Branch, said Vern Child, Ribi's vice president for finance. That cleared the way for a six-month "fast track" review of the drug.
There is a cancer that each of us can prevent. Still, it continues to attack over 130,000 Americans each year while claiming the lives of 55,000 more. The problem is colon cancer.
Providing powerful new evidence of the potency of AIDS-fighting drug cocktails, scientists will report today that the medications succeed in squashing the AIDS virus in patients beyond detection for a year or longer. Still, nobody - not University of Miami researchers, not their scientific collaborators across the country, not even the patients who have benefited the most - is ready to proclaim the combination drug therapy a panacea. It is, undeniably, a scientific success story.
The Food and Drug Administration on Monday approved a bold, "deep brain" implant that promises to ease the uncontrollable tremors experienced by thousands of patients with Parkinson's disease and another, equally disabling disorder called "essential tremor." The deep brain stimulator, which has been available in Europe for several years, has enabled many patients once again to eat, drink, write and perform an array of daily living activities by themselves, said Dr. Michael J. Friedman, acting FDA commissioner.
The chance discovery that some pregnant lab mice are resistant to Kaposi's sarcoma, a form of cancer seen almost exclusively among AIDS patients, has yielded a promising new treatment for the disease. The treatment involves a hormone derived from the urine of pregnant women. Researchers found that injections directly into the tumor often make the cancer disappear.
Treating lung cancer with both chemotherapy and radiation almost triples the number of patients who live at least five years, says a new study. But researchers cautioned that even with combination therapy's improvement, the future remains bleak for lung cancer patients, as those who survive even five years are a minority.
Chemotherapy that preserves a patient's voice box and ability to speak is just as effective as surgery in treating some types of throat cancer, a study suggests. Cancer experts say these and other recent findings give new choices in how to treat the disease.
A drug derived from the bark of a Chinese tree was approved by the Food and Drug Administration Wednesday to help women whose ovarian cancer has progressed despite other treatments. Topotecan is the first of a new class of cancer drugs that inhibit an enzyme essential for the growth of tumors. It appears to work at least as well as the widely used ovarian cancer therapy Taxol.
Michelle Carew, daughter of baseball Hall of Famer Rod Carew, is to undergo an umbilical cord blood transplant Friday to treat her leukemia, her doctor said. Carew, 18, has been in Children's Hospital of Orange County since last September waiting for a bone marrow match.
A new drug to help diabetics is going on the market this week in the United States after being available for years in Europe and Japan. Precose, brand name for the drug acarbose, is for diabetics who are not dependent on insulin injections. It slows the digestion of carbohydrates to help regulate blood-sugar levels.
The Food and Drug Administration on Tuesday approved the first drug that prolongs the lives of patients with Lou Gehrig's disease, although the improvement in survival is slight. The disease, officially known as amyotrophic lateral sclerosis (ALS), affects about 30,000 Americans, attacking nerve cells in the brain and spinal cord and leaving them hard and shriveled. Over the course of the disease, which averages three to five years, patients' muscles progressively weaken, leading to paralysis, respiratory failure and death. Five thousand new cases are reported each year.